Lataa...
Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms
The calamity of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), COVID-19, is still a global human tragedy. To date, no specific antiviral drug or therapy has been able to break the widespread of SARS-CoV2. It has been generally believed that stimulating protective immunity via...
Tallennettuna:
| Julkaisussa: | Int Immunopharmacol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier B.V.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8049400/ https://ncbi.nlm.nih.gov/pubmed/33930707 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2021.107679 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|